Compare AMPX & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMPX | NNNN |
|---|---|---|
| Founded | 2008 | 2021 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | N/A | 2025 |
| Metric | AMPX | NNNN |
|---|---|---|
| Price | $7.84 | $29.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $13.33 | N/A |
| AVG Volume (30 Days) | ★ 5.4M | 38.1K |
| Earning Date | 11-06-2025 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | ★ $58,408,000.00 | $8,185,146.00 |
| Revenue This Year | $205.06 | N/A |
| Revenue Next Year | $127.60 | N/A |
| P/E Ratio | ★ N/A | $599.13 |
| Revenue Growth | ★ 234.14 | 21.95 |
| 52 Week Low | $1.70 | $5.18 |
| 52 Week High | $16.03 | $55.65 |
| Indicator | AMPX | NNNN |
|---|---|---|
| Relative Strength Index (RSI) | 31.59 | 48.00 |
| Support Level | $8.77 | $31.18 |
| Resistance Level | $11.58 | $38.00 |
| Average True Range (ATR) | 0.69 | 4.21 |
| MACD | -0.23 | -0.24 |
| Stochastic Oscillator | 1.46 | 28.81 |
Amprius Technologies Inc is engaged in the production of silicon anodes for high-energy-density lithium-ion batteries. The company develops, manufactures and markets lithium-ion batteries for mobility applications, including the aviation, electric vehicle (EV) and light electric vehicle (LEV) industries. The company's batteries are used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites.
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.